Fireside chats

UiPath Announces Reboot Work Festival 2022 Featuring Keynotes and Customer Presentations on the Future of Automation

Retrieved on: 
Monday, April 4, 2022

UiPath (NYSE: PATH), a leading enterprise automation software company, today announced its global Reboot Work Festival a celebration of automation and a forum of new ideaswill take place virtually on April 12.

Key Points: 
  • UiPath (NYSE: PATH), a leading enterprise automation software company, today announced its global Reboot Work Festival a celebration of automation and a forum of new ideaswill take place virtually on April 12.
  • The Reboot Work Festival is expected to attract more than 10,000 people from the global automation community to hear big ideas and practical insights from UiPath experts and visionary customer leaders.
  • The festival kicks off with presentations in the Big Tent from the brightest minds in automation.
  • Register here for Reboot Work Festival 2022 and follow the festival on social media at #UiPathRebootWork.

1st Annual Web3 Law Conference Promises Stellar Speaker Lineup

Retrieved on: 
Friday, April 1, 2022

AUSTIN, Texas, April 1, 2022 /PRNewswire-PRWeb/ -- Web3 Law Center and the Web3 Law Conference are excited to announce the powerful speaker lineup set to appear at the inaugural conference April 7-8th, 2022. We are proud to announce that the keynote speaker is Dawn DeBerry Stump, Commissioner of the Commodity Futures Trading Commission (CFTC). At the conference, Mrs. Stump will be heading up an event titled 'Fireside Chat with the Commissioner' on April 7th. She will lend us her expertise in commodity futures, agriculture, and renewable energy matters.

Key Points: 
  • The inaugural 1st annual Web3 Law Conference convenes April 7-8, 2022 with a powerful lineup of industry experts.
  • AUSTIN, Texas, April 1, 2022 /PRNewswire-PRWeb/ -- Web3 Law Center and the Web3 Law Conference are excited to announce the powerful speaker lineup set to appear at the inaugural conference April 7-8th, 2022.
  • He will lend his expertise to the Web3 Law Conference speaking on Crypto, Government Surveillance & Civil Liberties.
  • It is the 1st annual conference sponsored by the Web3 Law Center.

Ulta Beauty to Participate in the J.P. Morgan Retail Round-Up Conference

Retrieved on: 
Thursday, March 31, 2022

At Ulta Beauty (NASDAQ: ULTA), the possibilities are beautiful.

Key Points: 
  • At Ulta Beauty (NASDAQ: ULTA), the possibilities are beautiful.
  • Ulta Beauty is the largest U.S. beauty retailer and the premier beauty destination for cosmetics, fragrance, skin care products, hair care products and salon services.
  • In 1990, the Company reinvented the beauty retail experience by offering a new way to shop for beauty bringing together all things beauty, all in one place.
  • Today, Ulta Beauty operates more than 1,300 retail stores across 50 states and also distributes its products through its website, which includes a collection of tips, tutorials, and social content.

Freeline to Participate in Upcoming Investor Conferences

Retrieved on: 
Wednesday, March 23, 2022

LONDON, March 23, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the Company or Freeline) today announced that senior management will participate in the following virtual investor conferences:

Key Points: 
  • LONDON, March 23, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the Company or Freeline) today announced that senior management will participate in the following virtual investor conferences:
    H.C. Wainwright Gene Therapy and Gene Editing Conference on March 30, 2022, where Chief Executive Officer Michael Parini will participate in a Fireside Chat.
  • 21st Annual Needham Virtual Healthcare Conference on April 11 14, 2022, where Chief Executive Officer Michael Parini will participate in a Fireside Chat.
  • Senior management will also participate in virtual one-on-one meetings with investors at both conferences as well as at the Guggenheim 3rd Annual Genomic Medicine and Rare Disease Day from March 31 April 1, 2022.
  • Freeline is headquartered in the UK and has operations in Germany and the US.

Usio to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest - March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

Retrieved on: 
Wednesday, March 23, 2022

The Company will participate in a Fireside Chat on Tuesday, March 29, 2022, from 9:30 10:00 AM.

Key Points: 
  • The Company will participate in a Fireside Chat on Tuesday, March 29, 2022, from 9:30 10:00 AM.
  • The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.
  • The Company operates credit, debit/prepaid, and ACH payment processing platforms to deliver convenient, world-class payment solutions and services to their clients.
  • Usio is headquartered in San Antonio, Texas, and has offices in Austin, Texas, and Franklin, Tennessee, just outside of Nashville.

OTTO Motors Launches World’s Smartest Autonomous Forklift

Retrieved on: 
Thursday, March 24, 2022

OTTO Motors , a leading provider of autonomous mobile robots (AMRs), today announced the availability of OTTO Lifter, the smartest autonomous forklift on the market.

Key Points: 
  • OTTO Motors , a leading provider of autonomous mobile robots (AMRs), today announced the availability of OTTO Lifter, the smartest autonomous forklift on the market.
  • The autonomous forklift is compatible with the entire OTTO Motors fleet of AMRs through OTTO Motors Fleet Manager.
  • Built on OTTO Motors industry-leading platform for autonomous materials handling, OTTO Lifters autonomy software makes intelligent, real-time decisions.
  • Were proud to bring our customers OTTO Motors fleet of autonomous mobile robots including their autonomous forklift, OTTO Lifter.

Asana to Present at Upcoming Investor Events

Retrieved on: 
Monday, March 21, 2022

Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), a leading work management platform for teams, today announced that Asanas executives will present at the following investor events:

Key Points: 
  • Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), a leading work management platform for teams, today announced that Asanas executives will present at the following investor events:
    Wolfe Research Virtual "March Madness" Software Conference, March 22, 2022 at 9:30 a.m. PT / 12:30 p.m.
  • Headquartered in San Francisco, CA, Asana has more than 119,000 paying customers and millions of free organizations across 190 countries.
  • Asana uses its investors.asana.com website as a means of disclosing material non-public information, announcing upcoming investor conferences and for complying with its disclosure obligations under Regulation FD.
  • Accordingly, you should monitor our investor relations website in addition to following our press releases, SEC filings, and public conference calls and webcasts.

Racing to Resolve the ‘Engagement Capacity Gap,’ Organizations Lean into Customer Service Technology for Digital-First Engagement and Empathy

Retrieved on: 
Tuesday, March 22, 2022

Fifty-two percent have customer engagement difficulties stemming from supply chain issues, while 71 percent find retaining talented workers to be moderately or highly challenging.

Key Points: 
  • Fifty-two percent have customer engagement difficulties stemming from supply chain issues, while 71 percent find retaining talented workers to be moderately or highly challenging.
  • Ninety-one percent have adopted technology and strategies to support greater empathy in their customer engagement efforts for 2022.
  • The Verint Customer Engagement portfolio draws on the latest advancements in AI and analytics, an open cloud architecture, and The Science of Customer Engagement to help customers close The Engagement Capacity Gap.
  • VERINT, VERINT DA VINCI, THE CUSTOMER ENGAGEMENT COMPANY, BOUNDLESS CUSTOMER ENGAGEMENT, THE ENGAGEMENT CAPACITY GAP and THE SCIENCE OF CUSTOMER ENGAGEMENT are trademarks of Verint Systems Inc. or its subsidiaries.

Acurx Pharmaceuticals to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28-30, 2022 from 9:00 a.m. - 5:00 p.m. EDT

Retrieved on: 
Wednesday, March 16, 2022

Mr. Luci will be presenting during the Fireside Chat with Acurx Pharmaceuticals, Inc. at 9:30 am ET on Monday, March 28, 2022.

Key Points: 
  • Mr. Luci will be presenting during the Fireside Chat with Acurx Pharmaceuticals, Inc. at 9:30 am ET on Monday, March 28, 2022.
  • The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.
  • About Acurx Pharmaceuticals, Inc. Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
  • However, while we may elect to update these forward- looking statements at some point in the future, we specifically disclaim any obligation to do so.

Iovance Biotherapeutics to Present at Upcoming Conferences

Retrieved on: 
Wednesday, March 16, 2022

SAN CARLOS, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that senior leadership plans to present at the following conferences in March:

Key Points: 
  • SAN CARLOS, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that senior leadership plans to present at the following conferences in March:
    Fireside Chat:March 16 at 12:40 p.m.
  • ET
    Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
  • We are pioneering a transformational approach to cure cancer by harnessing the human immune systems ability to recognize and destroy diverse cancer cells in each patient.
  • The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors.